Immunotherapy

AI agents for therapeutic reasoning across biological contexts

AI agents for therapeutic reasoning across biological contexts

Medea is an AI agent for therapeutic reasoning designed to overcome limitations of existing AI in preserving biological context, verifying computational steps, and reconciling conflicting evidence. It employs a modular architecture with robust verification mechanisms for research planning, analysis, literature reasoning, and multi-round discussion, demonstrating superior performance in cell type-specific target nomination, synthetic lethality prediction, and immunotherapy response prediction across various biological contexts and data types.

Inside Moderna’s Biggest mRNA Test Since COVID

Inside Moderna’s Biggest mRNA Test Since COVID

Moderna CEO Stéphane Bancel discusses the groundbreaking positive Phase 3 results for their individualized mRNA cancer vaccine combined with Keytruda for melanoma. He explains the personalized approach of sequencing patient tumors to teach the immune system specific cancer signatures, the engineering challenges of manufacturing a unique medicine for every patient, and Moderna's ambitious plans to expand this technology beyond melanoma to other cancers, rare genetic diseases, and autoimmune conditions.